Page 79 - Guide de prise en charge de la tuberculose en Tunisie 2018

REFERENCES

1. Rapport sur la lutte contre la tuberculose dans le monde. OMS 2017
(http://www.who.int/tb/publications/global_report/fr/).

2. Guidelines for treatment of tuberculosis, fourth edition. Geneva: World Health
Organization; 2010 (http://www.who.int/tb/publications/2010/9789241547833/en/,
accessed 27 February 2017)
3. Définitions et cadre de notification pour la tuberculose. OMS Révision 2013 (Mise à jour
décembre 2014).
4. Gallardo CR, et al. Fixed dose combinations of drugs versus single-drug formulations for
treating pulmonary tuberculosis. Cochrane Database Syst Rev. 2016;(5):CD009913

5. Lignes directrices pour le traitement de la tuberculose sensible aux médicaments et la prise
en charge du patient. Mise à jour 2017. Genève - OMS, 2017 (www.who.int)
6. Lignes directrices concernant la prise en charge de la tuberculose chez l’enfant dans le
cadre des programmes nationaux - 2ème edition, 2016). (www.who.int)

7. Mulenga H, et al. The Role of Clinical Symptoms in the Diagnosis of Intrathoracic
Tuberculosis in Young Children. Pediatr Infect Dis J. 2015;34(11):1157–62
8. Nahid P, et al. Official American Thoracic Society/Centers for Disease Control and
Prevention/Infectious Diseases Society of America Clinical Practice Guidelines. Treatment
of drug-susceptible tuberculosis. Clin Infect Dis. 2016; 63(7):e147-95.
9. Active tuberculosis drug-safety monitoring and management (aDSM). Framework for
implementation. WHO Documen Production Services, Geneva, Switzerland
WHO/HTM/TB/2015.28

10. Mfinanga S, et al. Early versus delayed initiation of highly active antiretroviral therapy for
HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a
prospective, international, randomised, placebo-controlled trial. Lancet Infect Dis.
2014;14:563–71
11. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV
infection 2016 recommendations for a public health approach second edition.
(www.who.int) World Health Organization 2016
12. The End TB Strategy Global strategy and targets for tuberculosis prevention, care and
control after 2015. WHA65/2012/REC/3 14 March 2014]

13. Zenner D, et al. Treatment of latent tuberculosis infection: An updated network meta-
analysis. Annals of Internal Medicine. 2017; 167(4):248–55.
14. WHO. Recommendation on 36 months isoniazid preventive therapy to adults and
adolescents living with HIV in resource-constrained and high TB and HIV-prevalence
settings: 2015 update. 2015
15. WHO. Latent tuberculosis infection Updated and consolidated guidelines for
programmatic management. Geneva: World Health Organization; 2018. Licence: CC BY-
NC-SA 3.0 IGO

16. WHO. Companion Handbook to the WHO Guidelines for the Programmatic Management

79 | P a ge